What is Beyond Air, Inc. (XAIR) stock price today?

Beyond Air, Inc. (XAIR) is currently trading at $2.25, down 2.6% today.

What is XAIR P/E ratio?

Beyond Air, Inc.'s P/E ratio is -0.05. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is XAIR return on equity (ROE)?

Beyond Air, Inc.'s return on equity (ROE) is -734.86%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Beyond Air, Inc.'s market cap?

Beyond Air, Inc. has a market capitalization of $1.62M.

NASDAQ · Medical - Devices

Beyond Air, Inc. (XAIR) Stock

$2.25 -2.60% NASDAQ: XAIR Healthcare

Valuation

Metric	Value
Price	$2.25
Market Cap	$1.62M
P/E Ratio	-0.05
P/B Ratio	1.03
P/S Ratio	0.27
EPS (TTM)	$-13.77
52-Week High	$55.60
52-Week Low	$2.20
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-734.86%
ROA	-101.83%
ROCE	-107.91%
Gross Margin	-1100.00%
Operating Margin	-1125.00%
Net Margin	-435.71%
Debt/Equity	1.21
Current Ratio	3.20

Annual Financials (USD)

Metric	2022	2023	2024	2025	2026
Revenue	$0	$0	$1.0M	$4.0M	$8.0M
Operating Profit	$-41.0M	$-52.0M	$-63.0M	$-45.0M	$-29.0M
Net Profit	$-43.0M	$-56.0M	$-60.0M	$-47.0M	$-33.0M
EPS	$-672.80	$-744.80	$-726.60	$-275.40	$-4.01
Op Margin	—	—	-5436.2%	-1202.1%	-378.2%

Balance Sheet (USD)

Metric	2022	2023	2024	2025	2026
Total Assets	$99.0M	$69.0M	$57.0M	$30.0M	$35.0M
Total Liabilities	$21.0M	$27.0M	$30.0M	$16.0M	$29.0M
Cash	$80.0M	$29.0M	$11.0M	$5.0M	$7.0M
Borrowings	$3.0M	$4.0M	$18.0M	$12.0M	$23.0M

Latest News

Beyond Air (XAIR) Q4 2026 Earnings Call Transcript Motley Fool · Jun 27, 2026 Beyond Air Inc (XAIR) Q4 2026 Earnings Call Highlights: Revenue Surge and Path to Profitability GuruFocus.com · Jun 26, 2026 Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update GlobeNewswire · Jun 26, 2026 Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast GlobeNewswire · Jun 22, 2026 Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting GlobeNewswire · Jun 10, 2026

Cash Flow (USD)

Metric	2022	2023	2024	2025	2026
Operating Cash Flow	$-23.0M	$-33.0M	$-56.0M	$-38.0M	$-18.0M
Investing Cash Flow	$-3.0M	$-24.0M	$-18.0M	$9.0M	$-5.0M
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$55.0M	$-51.0M	$-28.0M	$-7.0M	$7.0M
Free Cash Flow	$-25.0M	$-37.0M	$-62.0M	$-44.0M	$-19.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.03
FCF Yield	-954.41%
Quick Ratio	3.12
Interest Coverage	-29.70
Return 1Y	77.53%
Return 3Y	-92.56%
Return 5Y	-95.57%

Ownership

Insiders Held9.91%

Institutions Held9.67%

Institutions Float Held10.73%

Institutional Holder	Shares	Report Date
Balyasny Asset Management LP	23,208	2026-03-31
Murchinson Ltd.	16,499	2026-03-31
Geode Capital Management, LLC	7,972	2026-03-31
Daytona Street Capital LLC	7,843	2026-03-31
Bleichroeder LP	4,324	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AEONAEON Biopharma, Inc.	$0.28	-10.97%	-0.08	$12.19M	0.00%
BOLTBolt Biotherapeutics, Inc.	$4.11	+12.60%	-0.22	$7.90M	0.00%
CLRBCellectar Biosciences, Inc.	$1.45	+3.57%	-0.39	$11.59M	0.00%
CODXCo-Diagnostics, Inc.	$1.12	+2.75%	-0.04	$7.00M	0.00%
IINNInspira Technologies OXY B.H.N. Ltd.	$1.26	-5.97%	-2.80	$30.34M	0.00%

About Beyond Air, Inc.

Beyond Air, Inc. is led by CEO Amir Avniel, employs 107 people, headquartered in US, publicly traded since 2018.

Beyond Air, Inc. (XAIR) stock trades at $2.25 with a market capitalization of $1.62M. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 1.03, price-to-sales of 0.27. Over the past 52 weeks the stock has ranged between $2.20 and $55.60, and currently trades 96.0% below its 52-week high.

On profitability, Beyond Air, Inc. generates a return on equity (ROE) of -734.86%, return on capital employed of -107.91%, an operating margin of -1125.00%, a net profit margin of -435.71%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides